Skip to main content

Our scientists discuss the potential mechanisms of action of cannabidiol in reducing neuroinflammation in a mouse model of multiple sclerosis. Please join us for a conversation about a study published in 2018 in the Frontiers in Immunology Journal entitled: “Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells”, in which our scientists discuss how CBD may be used as an interesting agent to attenuate neuroinflammation and clinical signs in a mouse model of multiple sclerosis.

Zachary Moore

Author Zachary Moore

More posts by Zachary Moore